-
-
-
-
-
-
-
Merrimack Reports First Quarter 2023 Financial Results
-
-
-
-
-
-
-
Merrimack Reports First Quarter 2022 Financial Results
-
-
-
-
-
-
-
Merrimack Reports First Quarter 2020 Financial Results
-
-
-
-
-
-
-
Merrimack Reports Fourth Quarter and Full Year 2018 Financial Results
-
-
-
-
-
-
-
Merrimack Discontinues Phase 2 SHERLOC Study of MM-121 in Patients with Non-Small Cell Lung Cancer Due to Futility
-
-
-
-
-
-
-
Merrimack Pharma (MACK) Reports Q4 Loss of $0.89
-
-
-
-
-
-
-
Merrimack Reports Second Quarter 2017 Financial Results
-
1,224,874 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

